Demo

2423 Articles Matching "fda"

FDA Approves First Non-Opioid for Withdrawal

May 20, 2018 , MedicineNet
Title: FDA Approves First Non-Opioid for WithdrawalCategory: Health NewsCreated: 5/18/2018 12:00:00 AMLast Editorial Review: 5/18/2018 12:00:00...
Read more

FDA Approves First Drug Aimed at Preventing Migraines

May 20, 2018 , MedicineNet
Title: FDA Approves First Drug Aimed at Preventing MigrainesCategory: Health NewsCreated: 5/18/2018 12:00:00 AMLast Editorial Review: 5/18/2018 12:00:00...
Read more

FDA Approves First Non-Opioid for Withdrawal

May 20, 2018 , RxList
The FDA approved the first non-opioid drug, lofexidine hydrochloride (Lucemyra), to help treat symptoms of opioid withdrawal in...
Read more

FDA Approves First Non-Opioid for Withdrawal

May 19, 2018 , eMedicine Health
FDA Approves First Non-Opioid for...
Read more

FDA names and shames drug makers to encourage generic competition

May 19, 2018 , CNBC Health
Major pharmaceutical companies have spent billions of dollars in an effort to patent their products and avoid generic copies of blockbuster medicines, but the FDA commissioner has vowed to end this, the New York Times reports....
Read more
Demo

Most Americans Think The Opioid Epidemic Is A Problem — Just Not One That’s In Their Backyard

May 19, 2018 , Kaiser Health News
Less than a quarter of the people surveyed feel it's an emergency in their community, U.S. Surgeon General Jerome Adams said. In other news on the crisis: the FDA criticizes a big data provider over a mistake concerning the amount of fentanyl prescribed over the past year; Sen. Claire McCaskill (D-Mo.) wants information on steps a drugmaker has taken to mitigate the opioid epidemic; a House panel advances a package of bills dealing with the epidemic; and more....
Read more

FDA names drugmakers potentially acting to delay cheap generics

May 18, 2018 , Reuters
(Reuters) - The U.S. Food and Drug Administration on Thursday listed a number of drugmakers it said could be improperly blocking access to their medicines in order to delay generic competition....
Read more

FDA approves first non-opioid treatment for opioid withdrawal

May 18, 2018 , Drug Store News - Clinical Retail
The U.S. Food and Drug Administration has approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for management of opioid withdrawal symptoms in adults. Read More...
Read more

FDA approves new Amgen drug for prevention of migraines

May 18, 2018 , CNBC Health
Amgen won FDA approval on Thursday for the first drug to prevent migraine headaches in...
Read more

U.S. FDA approves Amgen drug for prevention of migraines

May 18, 2018 , Reuters
(Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults....
Read more

FDA Approves First Non-Opioid for Withdrawal

May 18, 2018 , WebMD
The FDA found the drug to be safe and effective in easing symptoms such as diarrhea, nausea, vomiting, anxiety, and an overall feeling of sickness that often keep patients from withdrawing from...
Read more
Demo

FDA calls out drugmakers to promote greater generic competition

May 18, 2018 , Modern Healthcare Breaking News
The FDA claimed 39 drug companies may be blocking generic-drug makers from obtaining samples of their branded products to hinder generic...
Read more

FDA ramps up efforts to address youth use of e-cigarettes

May 18, 2018 , Drug Store News - Clinical Retail
The U.S. Food and Drug Administration is requesting information, such as documents related to product marketing and research on product design, from four e-cigarette manufacturers as part of its effort to address the use of e-cigarettes among kids. Read More...
Read more

FDA says harvest season over for E. coli-linked romaine lettuce

May 18, 2018 , CNBC Health
The harvest season for romaine lettuce, linked to the multi-state E. coli outbreak, is...
Read more

MC10 gets its first FDA clearance for BioStamp nPoint, a sensor platform for clinical trials

May 18, 2018 jonah.comstock@mobihealthnews.com (Jonah Comstock), Mobile Health News
Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system. BioStamp nPoint is a more advanced version of the company's non-FDA cleared...
Read more

FDA Approves Amgen's Migraine Drug

May 18, 2018 , Forbes
The drug’s list price is $6,900 per year, or $575 per monthly injected dose, lower than many market-watchers...
Read more

Egg Farm at Center of Salmonella Outbreak Had Rodents: FDA

May 18, 2018 , MedicineNet
Title: Egg Farm at Center of Salmonella Outbreak Had Rodents: FDACategory: Health NewsCreated: 5/17/2018 12:00:00 AMLast Editorial Review: 5/17/2018 12:00:00...
Read more

FDA Approves First of New Migraine Drugs

May 18, 2018 , WebMD
The FDA has approved the first in a new class of migraine drugs, called CGRP inhibitors, that aim to head off fight painful migraine headaches before they...
Read more

FDA approves first nonopioid drug to ease withdrawal symptoms

May 18, 2018 , CNBC Health
The U.S. FDA approved the first nonopioid treatment to ease withdrawal from quitting addictive opioids....
Read more

FDA approves generic Methergine tablets

May 18, 2018 , Drug Store News - Clinical Retail
The approval is Granules’ first, and the company said it also would be the first generic for the product, marketed by Lupin, on the market. Read More...
Read more